Carl P. Bergstrom
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases, Chemical Synthesis and Analysis, Hepatitis C virus research, Computational Drug Discovery Methods
Most-Cited Works
- → Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor(2010)184 cited
- → Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase(2014)99 cited
- → The Amyloid-β Rise and γ-Secretase Inhibitor Potency Depend on the Level of Substrate Expression(2008)66 cited
- → Enantioselective Synthesis of (+)-Cyclophellitol(1995)53 cited
- → Overexpression and Large-Scale Purification of Recombinant Hamster Polymorphic ArylamineN-Acetyltransferase as a Dihydrofolate Reductase Fusion Protein(1997)45 cited
- → Diastereoselective Diels-Alder reactions of nonracemic 3- and 4-amino furans bound to polystyrene. A comparison of these reactions to their solution state analogues(1996)41 cited
- → Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus(2011)41 cited
- → Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): A γ-secretase inhibitor with Aβ lowering activity in a transgenic mouse model of Alzheimer’s disease(2007)30 cited
- → Limonin and Nomilin Inhibitory Effects on Chemical-Induced Tumorigenesis(2000)23 cited
- → Characterization of Hamster Recombinant Monomorphic and Polymorphic Arylamine N-Acetyltransferases(1998)16 cited